Related Experiment Video

Updated: May 23, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis

M P Amato1, V Saia, B Hakiki

  • 1Department of Neurology, University of Florence, Florence, Italy.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|April 20, 2012
PubMed

Insights

This study found no significant difference in chronic cerebrospinal venous insufficiency (CCSVI) between pediatric-onset multiple sclerosis (MS) patients and healthy controls. These findings do not support CCSVI as a cause of MS.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Pediatric Neurology

Background:

  • Chronic cerebrospinal venous insufficiency (CCSVI) has been proposed as a potential cause of multiple sclerosis (MS).
  • Pediatric-onset MS (POMS) offers a unique opportunity to investigate risk factors near disease onset.
  • Understanding the role of CCSVI in POMS is crucial for disease etiology research.

Purpose of the Study:

  • To investigate the prevalence of CCSVI in patients with pediatric-onset MS (POMS).
  • To compare CCSVI rates between POMS patients and healthy controls.
  • To explore the association between CCSVI and clinical features in POMS.

Main Methods:

  • Ultrasound assessment of internal jugular, vertebral, and intracranial veins was performed.
  • 15 POMS patients and 16 healthy controls were included in the study.
  • CCSVI was diagnosed based on predefined criteria, with assessors blinded to subject status.

Main Results:

  • The frequency of CCSVI was similar in both the POMS group and the control group (p > 0.05).
  • No significant differences in clinical characteristics were observed between CCSVI-positive and CCSVI-negative patients.
  • The study did not find a correlation between CCSVI and the presence or clinical features of POMS.

Conclusions:

  • The findings suggest that CCSVI is not a causative factor in pediatric-onset multiple sclerosis.
  • This study adds to the body of evidence questioning the role of CCSVI in the pathogenesis of MS.
  • Further research is needed to fully elucidate the factors contributing to MS development.
Abstract

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...